These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1036 related items for PubMed ID: 22093635
1. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma]. Wang MJ, Qi J, Wang H, Li XX, Wei BJ, Fu C, Gao J, Han BB. Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635 [Abstract] [Full Text] [Related]
2. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H. Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [Abstract] [Full Text] [Related]
3. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward? Azzam AZ, Hashad DI, Kamel NA. Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457 [Abstract] [Full Text] [Related]
4. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis. Kadija S, Stefanovic A, Jeremic K, Radojevic MM, Nikolic L, Markovic I, Atanackovic J. Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964 [Abstract] [Full Text] [Related]
5. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients. Li QL, Wang CJ, Qi P, Zhang YX. Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641 [Abstract] [Full Text] [Related]
6. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. Lenhard M, Stieber P, Hertlein L, Kirschenhofer A, Fürst S, Mayr D, Nagel D, Hofmann K, Krocker K, Burges A. Clin Chem Lab Med; 2011 Sep 16; 49(12):2081-8. PubMed ID: 21923475 [Abstract] [Full Text] [Related]
7. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses. Chen X, Zhou H, Chen R, He J, Wang Y, Huang L, Sun L, Duan C, Luo X, Yan H. Clin Chim Acta; 2015 Feb 02; 440():57-63. PubMed ID: 25447698 [Abstract] [Full Text] [Related]
8. HE4 and ROMA index in Czech postmenopausal women. Novotny Z, Presl J, Kucera R, Topolcan O, Vrzalova J, Fuchsova R, Betincova L, Rokyta Z. Anticancer Res; 2012 Sep 02; 32(9):4137-40. PubMed ID: 22993374 [Abstract] [Full Text] [Related]
10. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y, Li L. Tumour Biol; 2016 Nov 02; 37(11):14765-14772. PubMed ID: 27629144 [Abstract] [Full Text] [Related]
15. Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease. Zheng H, Gao Y. Int J Gynecol Cancer; 2012 Jul 02; 22(6):1000-5. PubMed ID: 22426406 [Abstract] [Full Text] [Related]
18. Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women. Yu S, Lee JK, Kim JH, Park H, Lee MY, Ryu S, Kwon MJ, Woo HY. Gynecol Oncol; 2016 Oct 02; 143(1):128-134. PubMed ID: 27426308 [Abstract] [Full Text] [Related]
20. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis. Zhang L, Chen Y, Wang K. Curr Probl Cancer; 2019 Apr 02; 43(2):135-144. PubMed ID: 30017407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]